secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspira Women's Health Inc. (AWHL)
CIK:        0000926617
Form:       8-K
Filed at:   2024-10-24T23:59:59+00:00
Accession:  0001493152-24-042315
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspira Women's Health awarded $10M ARPA-H grant for endometriosis blood test
----------------------------------------------------------------------------

- Selected by ARPA-H for Sprint for Women's Health; $10M funding over two years to develop ENDOinform blood test for endometriosis.
- First milestone expected Q4 2024; $2M payment upon successful acceptance.
- One of only six Launchpad awards among 1,700+ submissions; among largest awards approved.
- Virtual Investor Day scheduled for October 29, 2024 at 3:00 p.m. ET.
- ENDOinform aims to replace laparoscopic surgery for diagnosing endometriosis, affecting 6M women in US.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/926617/000149315224042315/0001493152-24-042315-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/926617/000149315224042315/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-042315

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer